CAPRELSA is a kinase inhibitor indicated for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of CAPRELSA (vandetanib) Tablets brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Lynparza (olaparib) tablets cost price in India.
The order for CAPRELSA (vandetanib) Tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Vandetanib (INN, trade name Caprelsa) is an anti-cancer drug that is used for the treatment of certain tumours of the thyroid gland. It acts as a kinase inhibitor of a number of cell receptors, mainly the vascular endothelial growth factor receptor (VEGFR), the epidermal growth factor receptor (EGFR), and the RET-tyrosine kinase.
CAPRELSA® (vandetanib) Tablets for Oral use Initial U.S. Approval: 2011/p>
Generic Name: vandetanib
100 mg and 300 mg tablets
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand CAPRELSA (vandetanib) Tablets on prescription and Import License in Patient's Name only.
For overseas patients, CAPRELSA (vandetanib) Tablets can be made available in Send your enquiry to find CAPRELSA (vandetanib) Tablets in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For CAPRELSA (vandetanib) Tablets Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Vandetanib shows promise for advanced thyroid cancer For More Details
LOXO-292 Receives Breakthrough Designation From FDA for NSCLC, MTCReadMore